Vident Advisory’s Innoviva INVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$722K Buy
31,773
+3,385
+12% +$77.5K 0.01% 1166
2026
Q1
$661K Buy
28,388
+121
+0.4% +$2.61K 0.01% 1094
2025
Q4
$565K Buy
+28,267
New +$552K 0.01% 1104
2025
Q1
Sell
-26,687
Closed -$463K 1590
2024
Q4
$463K Buy
26,687
+2,637
+11% +$50.6K 0.01% 993
2024
Q3
$464K Sell
24,050
-7,341
-23% -$135K 0.01% 962
2024
Q2
$515K Buy
+31,391
New +$487K 0.01% 861

Other funds holding INVA

Vident Advisory's INVA Position: Q2 2026 in Review

Vident Advisory increased its Innoviva (INVA) stake by 12% in Q2 2026, buying an estimated $77.5K and bringing the position to 31,773 shares worth $722K. The position accounts for 0.01% of the portfolio, ranked #1166.

Vident Advisory first reported a position in INVA in Q2 2024 and has held it in 6 quarters since. 308 funds tracked by Wall St. Rank hold INVA as of Q2 2026.

  • Vident Advisory held 31,773 shares of Innoviva worth $722K as of Q2 2026.
  • Vident Advisory bought 3,385 Innoviva shares in Q2 2026, an estimated $77.5K.
  • Innoviva made up 0.01% of Vident Advisory's portfolio in Q2 2026, its #1166 holding.
  • Vident Advisory first reported a position in Innoviva in Q2 2024 and has held it in 6 quarters since.
  • 308 funds tracked by Wall St. Rank held Innoviva as of Q2 2026.

Based on Vident Advisory's 13F filing for Q2 2026, filed 12 Aug 2026.